The White House has withdrawn President Donald Trump’s nomination of Heidi Overton to lead the Food and Drug Administration, and Sen. Roger Marshall (R-KS) is now being discussed as a possible replacement, according to multiple reports.
Axios reported Tuesday evening that the decision to drop Overton’s nomination came ahead of a scheduled Wednesday vote by the Senate Health, Education, Labor, and Pensions Committee.
A separate Tuesday report from Semafor, citing four people familiar with the matter, said Republicans are discussing Marshall as a possible successor to Overton, whose nomination ran into opposition from both anti-abortion activists and moderate Republicans.
Marshall, a physician who lost his reelection bid earlier this month, is reportedly seen as a stronger bet for Senate confirmation. Republicans are working against the clock to confirm Trump’s nominees before Democrats take control of the Senate in January.
“Marshall is viewed as an alternative if Heidi can’t make it through,” a Trump administration official told Semafor. “Senators have an easier time getting confirmed, traditionally. At this point, it’s hard to get anyone approved.”
“There is a growing view in the Senate that a senator would be the only person while we’ve got a majority, so Roger Marshall’s name is quickly percolating as a person who would be confirmable,” a senior Republican aide told Semafor.
It is not yet clear whether the White House will formally pursue Marshall or turn to another candidate if Overton’s bid collapses entirely, especially with so little time left before the Senate majority shifts. The White House did not immediately comment, according to Semafor, and Marshall’s office declined to comment.
An Agency Without a Permanent Leader
The FDA has gone without a permanent commissioner since former Commissioner Marty Makary was pushed out in May following disputes with the White House over flavored vaping products. Makary also faced pressure from anti-abortion Republicans who wanted tighter restrictions on mifepristone, a drug used in medication abortions.
After Makary’s exit, Kyle Diamantas, an attorney who previously served as the FDA’s top food official, became acting commissioner and reportedly built a reputation as a steady administrator who helped stabilize the agency. But a Trump administration official told Semafor that Diamantas never wanted the job permanently and is weighing leaving the FDA regardless of how the Overton nomination plays out.
Marshall’s Kansas Loss
Marshall lost his Senate reelection bid earlier this month to Democrat Adam Hamilton, a Methodist megachurch pastor, in a race widely viewed as a tossup. NBC News called the race for Hamilton, making him the first Democrat elected to the U.S. Senate from Kansas since 1932.
Hamilton has previously said he believes the Bible contains errors, that Christians are not required to believe in the virgin birth of Jesus, that pagans who never believed in Jesus will nevertheless be saved by him, and that he can identify places where the Apostle Paul was wrong in scripture. His church has also encouraged gender-neutral language in its children’s ministry.




